STAT+: Pharmalittle: J&J seeks emergency use for its coronavirus vaccine; Merck says parasite drug does not work on Covid-19
And so, another working week will soon draw to a close. Not a moment too…
Category: Pharma
STAT+: Pharmalittle: Switzerland rejects AstraZeneca Covid-19 vaccine; McKinsey to pay $573 million over its role in opioid crisis
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
McKinsey agrees to $573 million settlement over advice given Purdue and other opioid makers
The McKinsey & Co. consulting firm has reached a $573 million settlement with 47 states…
Why some hospitals have to scramble for oxygen to treat Covid-19 patients
As Covid-19 cases began spiking last month, Mara Bryant and her hospital staff had to…
STAT+: Pharmalittle: GSK to partner with CureVac on Covid-19 vaccine; Jazz to buy GW Pharma in $7.2 billion deal
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Jazz Pharmaceuticals said Wednesday that it is acquiring GW Pharma, adding an approved childhood epilepsy…
STAT+: Pharmalittle: Russia’s Covid-19 vaccine appears effective; BioCryst stock is pursued by Reddit investors
Rise and shine, everyone, another busy day is on the way. Once again, however, events…
STAT+: Pharmacy benefit managers take heavy criticism from a new source: local officials
In what is being described as an unusual move, a Pennsylvania county is openly blaming…
.jpg)
STAT+: Pharmalittle: AstraZeneca to boost Covid-19 vaccine supplies to EU; what comes next for Biogen’s Alzheimer’s drug?
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: J&J and Novavax vaccines are effective to varying degrees; FDA delays decision on Biogen Alzheimer’s drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: U.S. wholesalers bid to distribute Covid-19 shots; U.S. drug prices were 2.5 times higher than in other countries
Top of the morning to you, and a fine one, it is. We can tell…
STAT+: U.S. drug prices were more than double those in dozens of countries in 2018
As debate intensifies over the cost of medicines, a new analysis found that prescription drug…
STAT+: Advocacy groups urge Biden administration not to tap Woodcock as FDA commissioner
As the Biden White House attempts to fashion its health policies, a coalition of consumer…
STAT+: Pharma is only ‘inching forward’ in boosting access to medicines in low-income countries
Like the proverbial tortoise, a new analysis finds that while the pharmaceutical industry is taking…
‘Use that money wisely’: Coalition urges governments to spend opioid settlement funds on evidence-based efforts
As state and local governments consider how to spend proceeds from settlements with opioid makers,…
STAT+: Pharmalittle: EU and AstraZeneca clash over Covid-19 vaccine; J&J is bullish about vaccine supplies
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+: This professor wrote a manual for using a little-known federal law for lowering drug prices
One of the priorities of the new Biden administration is to tackle the cost of…
STAT+: FTC sues drug makers over allegedly illegal deal over an opioid painkiller
For the second time, the Federal Trade Commission has filed a lawsuit alleging Endo International…
STAT+: Pharmalittle: Regeneron says its antibody prevented Covid-19 in a trial; EU threatens to impose vaccine export controls
Rise and shine, folks, another busy day is on the way. We can tell because…
STAT+: European Ombudsman probes failure to disclose Covid-19 vaccine contracts
In response to concerns that key terms of Covid-19 vaccine deals remain hidden, the European…
STAT+: Pharmalittle: Merck halts development of Covid-19 vaccines; Moderna starts work on booster shot to combat variants
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Pfizer agrees to supply Covid-19 vaccine to WHO Covax program; FDA approves first injectable HIV medicine
And so, another working week will soon draw to a close. Not a moment too…
FDA approves first monthly injectable medicine to treat HIV infection
In a move that could transform HIV treatment, the Food and Drug Administration has approved…
STAT+: Canada’s drug makers rattle their sabers over a government plan to control medicine spending
A majority of pharmaceutical executives in Canada say new regulations designed to cut prescription drug…
STAT+: Pharmalittle: Lilly says its antibody prevented Covid-19 in a trial; EU and Pfizer clash over vaccine delays
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: The CEO of Mark Cuban’s generics company talks drug prices, manufacturing, and his famous boss
In a surprise move, Mark Cuban last week announced plans to enter the generic drug…
STAT+: How much? Hospitals mark up some medicines by 250% on average
As Americans grapple with the rising cost of prescription drugs, a new analysis found that…
STAT+: Pharmalittle: Pfizer and BioNTech say vaccine is effective against Covid-19 variant; U.S. to join COVAX initiative
Top of the morning to you, and a fine one it is, as the much-discussed…
STAT+: Pharmalittle: U.S. health officials seek more use of Covid-19 antibody drugs; Pfizer to reduce vaccine supplies to Europe
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Family medicine residents don’t interact with pharma as much as they once did
Amid concerns about pharmaceutical industry influence on physicians, a new survey finds fewer family medicine…
STAT+: Will the FTC get tougher on pharma business practices under the Biden administration?
As the Biden administration begins setting priorities, the Federal Trade Commission is poised to take…
STAT+: Maryland Senate overrides governor’s veto of prescription drug affordability board
In response to the rising cost of medicines, the Maryland state Senate overrode a veto…
STAT+: Pharmalittle: Biden taps Kessler to lead Operation Warp Speed; Trump administration seeks term limits on top FDA, CDC scientists
And so, another working week will soon come to a close. Not a moment too…
STAT+: Medicare Part D spent twice what the VA paid for the same drugs
Medicare Part D spent more than twice as much on hundreds of prescription drugs than…
STAT+: Drug makers sue HHS over a discount program serving low-income populations
In a clutch of lawsuits, three drug makers argue the federal government is wrong to…
STAT+: Pharmalittle: J&J Covid-19 vaccine data show some immunity after one dose; Biden may tap Sharfstein to run the FDA
Top of the morning to you, and a fine one it is. Despite the perennial…
STAT+: Former Merck employee arrested for stealing trade secrets on cancer research
A former Merck (MRK) cancer researcher was arrested and charged with stealing a raft of…
STAT+: Mark Cuban wades into the generic drug shark tank with a new company
Mark Cuban turns down new business opportunities on Shark Tank by declaring “I’m out!” But…
STAT+: Pharmalittle: J&J Covid-19 vaccine production is behind schedule; Slaoui resigns from Operation Warp Speed
Rise and shine, everyone, the middle of the week is already here, which means we…
STAT+: Endocrinologists urge federal lawmakers to act to lower insulin costs
Amid ongoing concerns over the cost of insulin, a leading physicians group is calling for…
STAT+: Pharmalittle: Pfizer to boost Covid-19 vaccine production; HHS overrules FDA on its top lawyer pick
Hello, everyone, and how are you today? We are doing just fine, thank you, now…
STAT+: The prices of 7 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2019
During 2019, drug makers raised prices on seven widely used medicines by substantial amounts without…
STAT+: Commerce Department agency proposes eliminating ‘march-in rights’ as a tool to lower drug prices
In a little-noticed move, a Commerce Department unit has proposed a new rule that would…
STAT+: A Covid-19 vaccine maker in India stirs controversy over its clinical trial
For the second time in two weeks, patient groups in India are raising concerns about…
STAT+: Pharmalittle: Lilly says Alzheimer’s drug may slow cognitive decline; half-dose of AstraZeneca Covid-19 shot may not work
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Tennessee to become the first state to run a closed Medicaid drug formulary
In a first-of-its-kind move, the Trump administration will allow Tennessee officials to restrict medicines covered…
STAT+: FDA advisory panel meetings became ‘rarer and tougher’ in 2020
Among the myriad changes wrought by the Covid-19 pandemic, Food and Drug Administration advisory committee…
STAT+: Pharmalittle: Pfizer-BioNTech vaccine seems to work against Covid-19 mutation; Sarepta gene therapy shows mixed results
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Slaoui to become Warp Speed consultant; CureVac teams with Bayer for Covid-19 vaccine help
Good morning, everyone, and how are you today? Like many others, we are forging ahead…
STAT+: Generic drug makers fear a ‘skinny labeling’ court ruling will pose a huge threat
An arcane regulatory term known as skinny labeling may have a funny ring to it,…